News

Ophthalmology Times6h

Re-Vana and Boehringer Ingelheim launch $1B collaboration to develop extended-release eye therapies

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
Ophthalmology Times10h

CORXEL submits NDA for LNZ100 in China for presbyopia treatment

LENZ Therapeutics previously licensed Greater China rights to CORXEL for the development and commercialization of LNZ100 in April 2022.